Dyne Therapeutics (DYN) Assets Average (2020 - 2026)

Dyne Therapeutics (DYN) has reported Assets Average for 7 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Assets Average rose 43.03% year-over-year to $1.0 billion; the TTM figure through Jun 2026 stood at $1.0 billion (up 43.03% YoY), while the FY2025 annual figure was $939.1 million, up 119.33% from the prior year.
• Assets Average fell to $1.0 billion in Q2 2026 per DYN's latest filing, from $1.1 billion in the prior quarter.
• Across five years, Assets Average topped out at $1.1 billion in Q1 2026 and bottomed at $185.2 million in Q4 2023.
• Historically, Assets Average has averaged $574.8 million across 5 years, with a median of $540.4 million in 2022.
• Annual changes were most pronounced in 2023 — Assets Average sank 38.89% — and 2024, when it jumped 294.27%.
• Dyne Therapeutics' Assets Average stood at $303.0 million in 2022, then tumbled by 38.89% to $185.2 million in 2023, then surged by 294.27% to $730.0 million in 2024, then soared by 40.68% to $1.0 billion in 2025, then gained by 0.97% to $1.0 billion in 2026.
• Business Quant data shows DYN's Assets Average at $1.0 billion in Q2 2026, $1.1 billion in Q1 2026, and $1.0 billion in Q4 2025.